[1]
2026. Low Risk for Recurrence of Differentiated Thyroid Cancer:  A Paradigm Shift to De-Escalation and Simplifying Care for Long Term Follow-up. Canadian Diabetes & Endocrinology Today. 4, 2 (Aug. 2026), 22–28. DOI:https://doi.org/10.58931/cdet.2026.4256.